NCT02363283 · Interventional trial
Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma
Overall registry status Completed
Phase 2
Conditions Recurrent Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7
Delaware Valley sites
- University of Pennsylvania/Abramson Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory